You are here: Home Legal / Law Other Diabetes Drug Actos Possibly Linked to Bladder Cancer

Diabetes Drug Actos Possibly Linked to Bladder Cancer

January 6, 2012 Other news in Parkland,Florida, United States of America

The defective drug lawyers at Baker Zimmerman & Perez are investigating Actos claims.




FOR IMMEDIATE RELEASE
Parkland, Florida, United States of America (Free-Press-Release.com) January 6, 2012 -- CONTACT:
Robert B. Baker, Esq., Baker, Zimmerman & Perez
(954) 509-1900
BZLAW1@Yahoo.com
Kim Sailer, BARD Marketing/PR
ksailer@bardmarketing.com

Diabetes Drug Actos Possibly Linked to Bladder Cancer

Parkland, FL – In June 2011, the FDA (http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm) announced that patients who used the diabetes medication Actos for more than a year may have an increased risk of developing bladder cancer.

Manufactured by Takeda Pharmaceuticals, Actos (http://www.actos.com/WhatIsIt.aspx) is a prescription medication used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes. Often used an alternative to Avandia, some consumers also claim increased incidents of heart attack, stroke, and congestive heart failure and even death while using the drug.

Actos users who have experienced signs or symptoms of blood in urine, painful urination, frequent and urgent urination, frequent urinary tract infections and lower back or abdominal back pain, may be due to bladder cancer and should contact their doctor immediately.  

In 2010, U.S. sales of Actos was $3.5 billion, according to a CNBC (http://www.cnbc.com/id/43025869/America_s_Top_Selling_Prescription_Drugs?slide=3) report. And Actos was one of America’s 10 most popular prescription drugs according to IMS Institute for Healthcare Informatics (http://www.imshealth.com/portal/site/imshealth/menuitem.a46c6d4df3db4b3d88f611019418c22a/?vgnextoid=1648679328d6f210VgnVCM100000ed152ca2RCRD&vgnextchannel=41a67900b55a5110VgnVCM10000071812ca2RCRD&vgnextfmt=default). Sales in 2011 were nearing $4.3 billion.

Numerous states have lawsuits alleging negligence and failure to warn of the risks associated with the medication. Law suits in California and Louisiana recently have been consolidated before federal judges in their respective states.

The law does limit the time in which you can file a claim (statute of limitation). If you are taking or have taken Actos and have experienced symptoms or want to know your legal rights contact, Baker Zimmerman & Perez toll free at 800-886-LAWS or visit http://www.defendingtheinjured.com. The defective drug lawyers at Baker Zimmerman & Perez are also investigating claims involving, Fosamax, Paxil, Yaz, and others.

Did you know that tens of millions of Americans take prescription drugs and over the counter medications? According to the Center for Disease Control nearly half of all Americans use prescription drugs on a regular basis. Nearly a third of Americans use two or more drugs, and more than one in ten uses five or more prescription drugs regularly.

A major concern with all this drug usage is that the average consumer often never hears of drug recalls or the serious side effects. To learn more about drug safety alerts, drug recalls, market withdrawals, drug classes – I, II and III, and drug enforcement reports, visit the FDA’s website at http://www.fda.gov/drugs/drugsafety/DrugRecalls/default.htm to stay safe and informed.

Baker, Zimmerman & Perez, a Boca Raton / Parkland civil litigation firm, focuses on Catastrophic Personal Injury, Wrongful Death, Burn Injuries, and Defective Products and Drugs (http://www.bakerzimmerman.com/Drug_Pharmaceutical). The firm is headquartered at 6991 North State Road 7, Second Floor and may be reached at (954) 509-1900. Additional information about Robert Baker and Baker Zimmerman & Perez, P.A. may be obtained from the firm’s website at http://www.defendingtheinjured.com.


free-press-release.com Actos     Baker Zimmerman Perez     bladder cancer     diabetes     fda     prescription drugs     yaz

Share |


Contact Information

  • Name: BARD-Marketing

    Company: BARD Marketing

    Email: ***@bardmarketing.com





Upcoming Trade ShowNew Press NewsNew Exclusive News More Press News

  • FIA When: 2012.06.02~2012.06.08
    Where: Algiers,Algeria
  • ATOMEXPO When: 2012.06.04~2012.06.06
    Where: Moscow,Russia
  • BEA When: 2012.06.04~2012.06.07
    Where: New York,United States


  • Post your news to the World.See you news here immediately. It's easy and free!
    Create free account or Login.